Mangrove Partners’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-199,431	Closed	-$7.64M	–	375
2022 Q2	$7.64M	Buy	199,431 +17,736	+10%	+$679K	0.37%	67
2022 Q1	$7.52M	Buy	+181,695	New	+$7.52M	0.41%	46
2021 Q4	–	Hold	0	–	–	–	512